Potential clinical factors associated with secukinumab dose selection in the treatment of hidradenitis suppurativa: a cohort study of 132 patients
Saved in:
| Main Authors: | Alberto Soto Moreno, Sofía Haselgruber, Giovanna F. Osorio-Gomez, Pablo Fernandez-Crehuet, Juan Ortiz-Alvarez, Juan M. Segura-Palacios, Pedro Navarro-Guillamon, Alicia Padial Gomez-Torrente, Maria D. Fernandez- Ballesteros, Jose M. Llamas-Molina, Fiorella Vasquez-Chinchay, Claudia Guerrero-Ramirez, Marisol Contreras-Steyls, Marina Romero-Bravo, Alejandro Molina-Leyva |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Taylor & Francis Group
2025-12-01
|
| Series: | Journal of Dermatological Treatment |
| Online Access: | https://www.tandfonline.com/doi/10.1080/09546634.2025.2512156 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Secukinumab Treatment in Patients With Hidradenitis Suppurativa in Real-World Clinical Settings: A Multicenter Study
by: Ece Erbağcı, et al.
Published: (2025-01-01) -
Skin Homeostasis is Impaired in Hidradenitis Suppurativa Lesions: A Comparative Study
by: A. Soto-Moreno, et al.
Published: (2025-05-01) -
Potential Role of Ozenoxacin 1% Cream in the Topical Management of Hidradenitis Suppurativa: A Single-centre Experience (44 patients)
by: Pablo Fernández-Crehuet, et al.
Published: (2025-07-01) -
Surgical Approach to Hidradenitis Suppurativa
by: L. Mateu-Arrom, et al.
Published: (2025-06-01) -
Hidradenitis suppurativa and daily lifestyle
by: Natsuko Saito-Sasaki, et al.
Published: (2025-06-01)